INBRAIN Neuroelectronics develops ultrathin neural implants based on graphene technology for bidirectional interaction with the brain. The company’s implants are less than 10 micrometers thick and are designed to conform closely to neural tissue. Its platform combines advanced materials with implantable electronics to enable precise neural recording and stimulation. INBRAIN Neuroelectronics positions its technology within regulated clinical and therapeutic development contexts.

The technology uses graphene electrodes to achieve high signal fidelity while minimizing tissue disruption and inflammatory response. These electrodes support both neural sensing and electrical stimulation, enabling closed-loop modulation of brain activity. AI-driven signal processing is applied to interpret neural data and adapt stimulation parameters over time. This combination is intended to support precise, responsive neuromodulation in chronic neurological conditions.

INBRAIN Neuroelectronics targets neurological disorders such as Parkinson’s disease, where fine-grained modulation of neural circuits is critical. The platform is intended for use within clinical research and therapeutic pathways rather than consumer applications. Its focus reflects broader efforts to advance implantable neurotechnology through novel materials that improve biocompatibility, scalability, and long-term performance.